Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Persson

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
European Journal of Heart Failure|June 3, 2015
New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) StudyErwan Donal, Lars H Lund, Emmanuel Oger, et al.
Frontiers in Cardiovascular Medicine|November 4, 2022
Extracellular vesicles in heart failure - A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass graftingDmitri Matan, Fariborz Mobarrez, Ulrika Löfström, et al.
Scientific Reports|March 9, 2024
Cardiac biopsies reveal differences in transcriptomics between left and right ventricle in patients with or without diagnostic signs of heart failureChristoffer Frisk, Sarbashis Das, Maria J Eriksson, et al.
ESC Heart Failure|May 28, 2024
Iron deficiency in new onset heart failure: association with clinical factors and quality of lifeCarin Corovic Cabrera, Mattias Ekström, Per Tornvall, et al.
Scandinavian Cardiovascular Journal : SCJ|September 24, 2020
Reorganization of heart failure management and improved outcome - the 4D HF ProjectDmitri Matan, Ulrika Löfström, Carin Corovic Cabrera, et al.
European Journal of Heart Failure|July 22, 2014
Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fractionLars H Lund, Erwan Donal, Emmanuel Oger, et al.
Scientific Reports|March 1, 2019
Transcriptomics of cardiac biopsies reveals differences in patients with or without diagnostic parameters for heart failure with preserved ejection fractionSarbashis Das, Christoffer Frisk, Maria J Eriksson, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 1, 2017
Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational studyMoman A Mohammad, Pontus Andell, Sasha Koul, et al.
Archives of Cardiovascular Diseases|January 7, 2014
Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) studyErwan Donal, Lars H Lund, Emmanuel Oger, et al.
ESC Heart Failure|April 12, 2026
Worse Long-Term Outcomes in New-Onset HFpEF vs HFrEF and HFmrEF: Findings from the Stockholm PREFERS StudyHans Persson, Anton Winderud, Camilla Hage, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
European Journal of Heart Failure|June 3, 2015
New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) StudyErwan Donal, Lars H Lund, Emmanuel Oger, et al.
Frontiers in Cardiovascular Medicine|November 4, 2022
Extracellular vesicles in heart failure - A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass graftingDmitri Matan, Fariborz Mobarrez, Ulrika Löfström, et al.
Scientific Reports|March 9, 2024
Cardiac biopsies reveal differences in transcriptomics between left and right ventricle in patients with or without diagnostic signs of heart failureChristoffer Frisk, Sarbashis Das, Maria J Eriksson, et al.
ESC Heart Failure|May 28, 2024
Iron deficiency in new onset heart failure: association with clinical factors and quality of lifeCarin Corovic Cabrera, Mattias Ekström, Per Tornvall, et al.
Scandinavian Cardiovascular Journal : SCJ|September 24, 2020
Reorganization of heart failure management and improved outcome - the 4D HF ProjectDmitri Matan, Ulrika Löfström, Carin Corovic Cabrera, et al.
European Journal of Heart Failure|July 22, 2014
Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fractionLars H Lund, Erwan Donal, Emmanuel Oger, et al.
Scientific Reports|March 1, 2019
Transcriptomics of cardiac biopsies reveals differences in patients with or without diagnostic parameters for heart failure with preserved ejection fractionSarbashis Das, Christoffer Frisk, Maria J Eriksson, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 1, 2017
Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational studyMoman A Mohammad, Pontus Andell, Sasha Koul, et al.
Archives of Cardiovascular Diseases|January 7, 2014
Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) studyErwan Donal, Lars H Lund, Emmanuel Oger, et al.
ESC Heart Failure|April 12, 2026
Worse Long-Term Outcomes in New-Onset HFpEF vs HFrEF and HFmrEF: Findings from the Stockholm PREFERS StudyHans Persson, Anton Winderud, Camilla Hage, et al.
Pageof 9